Hormone replacement in survivors of childhood cancer and brain tumors: safety and controversies-Reference-Cited by-同舟云学术

Hormone replacement in survivors of childhood cancer and brain tumors: safety and controversies

Published:2023-01-01 Issue:1 Volume:12 Page:
ISSN:2049-3614
Container-title:Endocrine Connections
language:
Short-container-title:

Author:

Maa van Roessel Ichelle¹²,Bakker Boudewijn¹²^ORCID,van Santen Hanneke M¹²^ORCID,Chemaitilly Wassim³^ORCID

Affiliation:

1. Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, AB Utrecht, The Netherlands

2. Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands

3. Division of Pediatric Endocrinology, UPMC Children’s Hospitalof Pittsburgh, Pittsburgh, Pennsylvania, USA

Abstract

Childhood cancer survivors are at risk for developing endocrine disorders, including deficits in growth hormone, thyroid hormone and sex hormones. The influence these hormones have on cell growth and metabolism has raised concerns regarding the safety of their use as treatments in survivors of childhood cancer and brain tumors. This article offers a summary of current knowledge, controversies and areas for future research pertaining to this area.

Publisher

Bioscientifica

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://ec.bioscientifica.com/downloadpdf/journals/ec/12/1/EC-22-0382.xml

Reference66 articles.

1. Childhood cancer treatments and associated endocrine late effects: a concise guide for the pediatric endocrinologist;Chemaitilly,2019

2. Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an Endocrine Society clinical practice guideline;Sklar,2018

3. Guidelines from the Dutch Childhood Oncology Group (DCOG)/SKION;Raphael,2014

4. Long term follow up of survivors of childhood cancer: a national clinical guideline,2013

5. Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors;van Iersel,2022